High‐speed counter‐current chromatography assisted preparative isolation of phenolic compounds from the flowers of Chrysanthemum morifolium cv. Fubaiju
Journal of Separation Science · 2023
DOI: 10.1002/jssc.202300172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2023. Verfasst von Xiaowei Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China. Hauptthemen laut MEDLINE: Chrysanthemum, Flowers, Phenols, Plant Extracts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program.
Abstract (Originalsprache)
Chrysanthemum morifolium cv. Fubaiju is rich in phenolic compounds with various benefits such as anti‐inflammatory, antioxidant, and cardiovascular protection. In this study, 12 phenolic compounds, including five flavonoid glycosides and seven quinic acid derivatives, were successfully separated from the flowers of Chrysanthemum morifolium cv. Fubaiju by high‐speed counter‐current chromatography and preparative high‐performance liquid chromatography. Ethyl acetate‐ n ‐butanol–acetonitrile–water–acetic acid (5:0.5:2.5:5:0.25, v/v/v/v/v) was selected as solvent system to separate six fractions from the flowers of Chrysanthemum morifolium cv. Fubaiju, and 20% aqueous acetonitrile (containing 0.1% formic acid) was chosen to be the elution solvent in preparative high‐performance liquid chromatography for purifying the fractions above. Luteolin‐7‐ O ‐ β ‐D‐glucoside ( 1 ), luteolin‐7‐ O ‐ β ‐D‐glucuronide ( 2 ), apigenin‐7‐ O ‐ β ‐D‐glucoside ( 3 ), luteolin‐7‐ O ‐ β ‐D‐rutinoside ( 4 ), diosmetin‐7‐ O ‐ β ‐D‐glucoside ( 5 ), chlorogenic acid ( 6 ), 1,5‐dicaffeoylquinic acid ( 7 ), 1,4‐dicaffeoylquinic acid ( 8 ), 3,4‐dicaffeoylquinic acid ( 9 ), 3,4‐dicaffeoyl‐epi‐quinic acid ( 10 ), 3,5‐dicaffeoylquinic acid ( 11 ), and 4,5‐dicaffeoylquinic acid ( 12 ) were isolated with purities all above 95%, respectively. In addition, all isolates were evaluated for their protective effects on H 2 O 2 ‐induced oxidative damage in adult retinal pigment epithelial cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
- Hubei Fenghuang Baiyunshan Pharmaceutical Co., Ltd., Macheng, P. R. China.
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, P. R. China.
ORCID-Profile: Hao Wang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
Zitieren
APA
Dong, X., Huang, H., Wang, R., Luo, S., Mi, Y., Pan, Y., Shen, W., Cui, J., Hu, X., Cheng, X., Shi, X., & Wang, H. (2023). High‐speed counter‐current chromatography assisted preparative isolation of phenolic compounds from the flowers of Chrysanthemum morifolium cv. Fubaiju. Journal of Separation Science. https://doi.org/10.1002/jssc.202300172
Vancouver
Dong X, Huang H, Wang R, Luo S, Mi Y, Pan Y, et al. High‐speed counter‐current chromatography assisted preparative isolation of phenolic compounds from the flowers of Chrysanthemum morifolium cv. Fubaiju. Journal of Separation Science. 2023. doi:10.1002/jssc.202300172
BibTeX
@article{Dong2023,
author = {Dong, Xiaowei and Huang, Hongping and Wang, Rong and Luo, Shiyu and Mi, Yahui and Pan, Yuqing and Shen, Wei and Cui, Jiamin and Hu, Xiaolong and Cheng, Xuexiang and Shi, Xinhong and Wang, Hao},
title = {High‐speed counter‐current chromatography assisted preparative isolation of phenolic compounds from the flowers of Chrysanthemum morifolium cv. Fubaiju},
journal = {Journal of Separation Science},
year = {2023},
doi = {10.1002/jssc.202300172}
}
EUVIMED